Pharmaceutical companies have always been some of the first to adopt cutting-edge technology. You want to be the first to bring ground-breaking treatments or vaccines to market. To do so, you need your workers to stay productive regardless of what device they’re using or where they are: in a lab with research teams, on the floor of a manufacturing plant or collaborating with business partners in the field.
While digital transformation enables better collaboration and productivity, it also exposes your valuable intellectual property (IP) to countless new risks. Any of your employees' devices or accounts could be compromised at any time. This would give cyber-attackers access to your proprietary data as it moves from the research labs to manufacturing to your sales representatives in the field.
Because pharmaceutical intellectual property (IP) is so valuable, it is the target of both private and state-sponsored cyberattacks. According to Lookout data, in the first quarter of 2021 alone, more than 1 in 5 mobile users in the pharmaceutical industry were exposed to a mobile phishing attack.